{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:24:19Z","timestamp":1793309059930,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:00:00Z","timestamp":1557619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00417-019-04347-6","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:31:26Z","timestamp":1557783086000},"page":"1547-1554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma"],"prefix":"10.1007","volume":"257","author":[{"given":"Matteo","family":"Fallico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Bonfiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Chronopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Caltabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Spatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,12]]},"reference":[{"key":"4347_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","volume":"127","author":"K G\u00fcnd\u00fcz","year":"1999","unstructured":"G\u00fcnd\u00fcz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 127:579\u2013589","journal-title":"Am J Ophthalmol"},{"key":"4347_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109\u2013122","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4347_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00006982-200605000-00007","volume":"26","author":"CL Shields","year":"2006","unstructured":"Shields CL, Demirci H, Marr BP, Mashayekhi A, Dai VV, Materin MA, Shields JA (2006) Intravitreal triamcinolone acetonide for acute radiation papillopathy. Retina 26(5):537\u2013544","journal-title":"Retina"},{"key":"4347_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/eye.1991.39","volume":"5","author":"DB Archer","year":"1991","unstructured":"Archer DB, Amoaku WM, Gardiner TA (1991) Radiation retinopathy \u2013 clinical, histopathological, ultrastructural and experimental correlations. Eye (Lond) 5(Pt 2:239\u2013251","journal-title":"Eye (Lond)"},{"key":"4347_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","volume":"106","author":"ES Gragoudas","year":"1999","unstructured":"Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM (1999) Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 106:1571\u20131577","journal-title":"Ophthalmology"},{"key":"4347_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/bjo.2004.052159","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger PT, Kirli M (2005) Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 89:730\u2013738","journal-title":"Br J Ophthalmol"},{"key":"4347_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.eye.6701637","volume":"19","author":"SJ Bakri","year":"2005","unstructured":"Bakri SJ, Beer PM (2005) Photodynamic therapy for maculopathy due to radiation retinopathy. Eye (Lond) 19:795\u2013799","journal-title":"Eye (Lond)"},{"issue":"4","key":"4347_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/IAE.0000000000001585","volume":"38","author":"A Russo","year":"2018","unstructured":"Russo A, Reibaldi M, Avitabile T et al (2018) Dexamethasone intravitreal implant vs ranibizumab in the treatment of macular edema secondary to brachytherapy for choroidal melanoma. Retina 38(4):788\u2013794","journal-title":"Retina"},{"key":"4347_CR9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ijrobp.2007.11.045","volume":"70","author":"PT Finger","year":"2008","unstructured":"Finger PT (2008) Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys 70:974\u2013977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4347_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archophthalmol.2009.376","volume":"128","author":"PT Finger","year":"2010","unstructured":"Finger PT, Chin KJ (2010) Intravitreous ranibizumab (Lucentis) for radiation maculopathy. Arch Ophthalmol 128:249\u2013252","journal-title":"Arch Ophthalmol"},{"key":"4347_CR11","first-page":"T2","volume":"114","author":"IK Kim","year":"2016","unstructured":"Kim IK, Lane AM, Jain P, Awh C, Gragoudas ES (2016) Ranibizumab for the prevention of radiation complications in patients treated with proton beam irradiation for choroidal melanoma. Trans Am Ophthalmol Soc 114:T2","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"4347_CR12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.ophtha.2015.01.025","volume":"122","author":"Y Ikuno","year":"2015","unstructured":"Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi T, MYRROR Investigators (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: The MYRROR Study. Ophthalmology 122(6):1220\u20131227","journal-title":"Ophthalmology"},{"issue":"5","key":"4347_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/bjo.2007.134874","volume":"92","author":"MW Stewart","year":"2008","unstructured":"Stewart MW, Rosenfeld PJ (2008) Predicted biological activity of intravitreal VEGF trap. Br J Ophthalmol 92(5):667\u2013668","journal-title":"Br J Ophthalmol"},{"key":"4347_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.ophtha.2011.03.020","volume":"118","author":"JS Heier","year":"2011","unstructured":"Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Brown DM, CLEAR-IT 2 Investigators (2011) The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology 118:1098\u20131106","journal-title":"Ophthalmology"},{"key":"4347_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ophtha.2011.02.039","volume":"118","author":"DM Brown","year":"2011","unstructured":"Brown DM, Heier JS, Ciulla T, Benz M, Abraham P, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Nguyen QD, CLEAR-IT 2 Investigators (2011) Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age related macular degeneration. Ophthalmology 118:1089\u20131097","journal-title":"Ophthalmology"},{"issue":"4","key":"4347_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000452163","volume":"3","author":"MA Khan","year":"2017","unstructured":"Khan MA, Mashayekhi A, Shields JA, Shields CL (2017) Intravitreal aflibercept as rescue therapy for post-radiation cystoid macular edema resistant to intravitreal bevacizumab: outcomes at 1 year. Ocul Oncol Pathol 3(4):313\u2013319","journal-title":"Ocul Oncol Pathol"},{"key":"4347_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/ICU.0b013e3283386687","volume":"21","author":"N Horgan","year":"2010","unstructured":"Horgan N, Shields CL, Mashayekhi A, Shields JA (2010) Classification and treatment of radiation maculopathy. Curr Opin Ophthalmol 21:233\u2013238","journal-title":"Curr Opin Ophthalmol"},{"key":"4347_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajo.2017.11.008","volume":"186","author":"P Oellers","year":"2018","unstructured":"Oellers P, Mowery YM, Perez BA et al (2018) Efficacy and safety of low-dose iodine plaque brachytherapy for juxtapapillary choroidal melanoma. Am J Ophthalmol 186:32\u201340","journal-title":"Am J Ophthalmol"},{"key":"4347_CR19","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1097\/IAE.0b013e31829234fa","volume":"33","author":"S Baillif","year":"2013","unstructured":"Baillif S, Maschi C, Gastaud P, Caujolle JP (2013) Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma. Retina 33:1784\u20131790","journal-title":"Retina"},{"issue":"3","key":"4347_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/IAE.0000000000000770","volume":"36","author":"KH Seo","year":"2016","unstructured":"Seo KH, Yu SY, Kim M, Kwak HW (2016) Visual and morphologic outcomes of intravitreal ranibizumab for diabetic macular edema based on optical coherence tomography patterns. Retina 36(3):588\u2013595","journal-title":"Retina"},{"issue":"6","key":"4347_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ajo.2012.06.008","volume":"154","author":"M Reibaldi","year":"2012","unstructured":"Reibaldi M, Parravano M, Varano M et al (2012) Foveal microstructure and functional parameters in lamellar macular hole. Am J Ophthalmol 154(6):974\u2013980","journal-title":"Am J Ophthalmol"},{"key":"4347_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0002-9394(14)73812-7","volume":"119","author":"JT Thompson","year":"1995","unstructured":"Thompson JT, Glaser BM, Sjaarda RN, Murphy RP (1995) Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 119:48\u201354","journal-title":"Am J Ophthalmol"},{"key":"4347_CR23","first-page":"627674","volume":"2015","author":"V Tah","year":"2015","unstructured":"Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, Ramskold L, Pasu S (2015) Anti-VEGF therapy and the retina: an update. J Ophthalmol 2015:627674","journal-title":"J Ophthalmol"},{"issue":"6","key":"4347_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.5301\/ejo.5000333","volume":"23","author":"PT Finger","year":"2013","unstructured":"Finger PT, Chin KJ (2013) High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy. Eur J Ophthalmol 23(6):850\u2013856","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"4347_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5301\/ejo.5000670","volume":"26","author":"PT Finger","year":"2016","unstructured":"Finger PT, Chin KJ, Semenova EA (2016) Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study. Eur J Ophthalmol 26(1):60\u201366","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"4347_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/archopht.125.6.751","volume":"125","author":"PT Finger","year":"2007","unstructured":"Finger PT, Chin K (2007) Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol 125(6):751\u2013756","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"4347_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/IAE.0b013e3181706302","volume":"28","author":"A Gupta","year":"2008","unstructured":"Gupta A, Muecke JS (2008) Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin). Retina 28(7):964\u2013968","journal-title":"Retina"},{"issue":"7","key":"4347_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/IAE.0b013e31806e6042","volume":"27","author":"JO Mason 3rd","year":"2007","unstructured":"Mason JO 3rd, Albert MA Jr, Persaud TO, Vail RS (2007) Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina 27(7):903\u2013907","journal-title":"Retina"},{"issue":"3","key":"4347_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000448719","volume":"3","author":"MA Khan","year":"2017","unstructured":"Khan MA, Mashayekhi A, Ferguson K, Shields JA, Shields CL (2017) High-dose (2.5 mg) intravitreal bevacizumab as rescue therapy for persistent postradiationcystoid macular edema. Ocul Oncol Pathol 3(3):168\u2013175","journal-title":"Ocul Oncol Pathol"},{"issue":"2","key":"4347_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5301\/ejo.5000352","volume":"24","author":"A Mashayekhi","year":"2014","unstructured":"Mashayekhi A, Rojanaporn D, Al-Dahmash S, Shields CL, Shields JA (2014) Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma. Eur J Ophthalmol 24(2):228\u2013234","journal-title":"Eur J Ophthalmol"},{"key":"4347_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1874364101610010103","volume":"10","author":"AW Stacey","year":"2016","unstructured":"Stacey AW, Demirci H (2016) Serial intravitreal bevacizumab injections slow the progression of radiation maculopathy following Iodine-125 plaque radiotherapy. Open Ophthalmol J 10:103\u2013110","journal-title":"Open Ophthalmol J"},{"key":"4347_CR32","first-page":"2017","volume":"9","author":"P Pooprasert","year":"2017","unstructured":"Pooprasert P, Young-Zvandasara T, Al-Bermani A (2017) Radiation retinopathy treated successfully with aflibercept. BMJ Case Rep 9:2017","journal-title":"BMJ Case Rep"},{"issue":"1","key":"4347_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000456535","volume":"8","author":"E Loukianou","year":"2017","unstructured":"Loukianou E, Loukianou G (2017) Intravitreal aflibercept in recalcitrant radiation maculopathy due to external beam radiotherapy for nasopharyngeal cancer: a first case report. Case Rep Ophthalmol 8(1):87\u201390","journal-title":"Case Rep Ophthalmol"},{"issue":"10","key":"4347_CR34","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00417-009-1107-5","volume":"247","author":"A Sakamoto","year":"2009","unstructured":"Sakamoto A, Nishijima K, Kita M, Oh H, Tsujikawa A, Yoshimura N (2009) Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 247(10):1325\u20131330","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4347_CR35","first-page":"1739","volume":"6","author":"NV Shah","year":"2012","unstructured":"Shah NV, Houston SK, Markoe AM, Feuer W, Murray TG (2012) Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity. Clin Ophthalmol 6:1739\u20131748","journal-title":"Clin Ophthalmol"},{"issue":"13","key":"4347_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR et al (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203","journal-title":"N Engl J Med"},{"key":"4347_CR37","doi-asserted-by":"publisher","unstructured":"Park DH, Sun HJ, Lee SJ (2016) A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration. Int Ophthalmol. \n                    https:\/\/doi.org\/10.1007\/s10792-016-0391-4","DOI":"10.1007\/s10792-016-0391-4"},{"issue":"1","key":"4347_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3928\/23258160-20150101-10","volume":"46","author":"AH Shaikh","year":"2015","unstructured":"Shaikh AH, Toussaint BW, Miller DM, Petersen MR, Foster RE, Riemann CD, Hutchins RK, Sisk RA (2015) Cost comparison of intravitreal aflibercept with bevacizumab and ranibizumab for the treatment of wet age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 46(1):62\u201366","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4347_CR39","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/IAE.0000000000000537","volume":"35","author":"JM Caminal","year":"2015","unstructured":"Caminal JM, Flores-Moreno I, Arias L et al (2015) Intravitreal dexamethasone implant for radiation maculopathy secondary to plaque brachytherapy in choroidal melanoma. Retina 35:1890\u20131897","journal-title":"Retina"},{"key":"4347_CR40","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1111\/aos.12424","volume":"92","author":"L Tarmann","year":"2014","unstructured":"Tarmann L, Langmann G, Mayer C et al (2014) Ozurdex reduces the retinal thickness in radiation maculopathy refractory to bevacizumab. Acta Ophthalmol 92:e694\u2013e696","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"4347_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000337144","volume":"3","author":"A Russo","year":"2012","unstructured":"Russo A, Avitabile T, Uva M et al (2012) Radiation macular edema after Ru-106 plaque brachytherapy for choroidal melanoma resolved by an intravitreal dexamethasone 0.7-mg implant. Case Rep Ophthalmol 3(1):71\u201376","journal-title":"Case Rep Ophthalmol"},{"issue":"10","key":"4347_CR42","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr et al (2014) Ozurdex MEAD study group three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121(10):1904\u20131914","journal-title":"Ophthalmology"},{"issue":"2","key":"4347_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/eye.2012.249","volume":"27","author":"C Groenewald","year":"2013","unstructured":"Groenewald C, Konstantinidis L, Damato B (2013) Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye (Lond) 27(2):163\u2013171","journal-title":"Eye (Lond)"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04347-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:08:24Z","timestamp":1589137704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04347-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,12]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4347"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04347-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736203232.793585170","asserted-by":"object"}]},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,12]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Matteo Fallico declares that he has no conflict of interest. Michele Reibaldi declares that he has no conflict of interest. Teresio Avitabile declares that he has no conflict of interest. Antonio Longo declares that he has no conflict of interest. Vincenza Bonfiglio declares that she has no conflict of interest. Argyrios Chronopoulos declares that he has no conflict of interest. Rosario Caltabiano declares that he has no conflict of interest. Corrado Spatola declares that he has no conflict of interest. Andrea Russo declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}